Natixis Advisors
CRL icon

Natixis Advisors’s Charles River Laboratories CRL Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$12.9M Sell
84,910
-138
-0.2% -$20.9K 0.02% 602
2025
Q1
$12.8M Buy
85,048
+6,609
+8% +$995K 0.02% 578
2024
Q4
$14.5M Sell
78,439
-5,704
-7% -$1.05M 0.03% 543
2024
Q3
$16.6M Sell
84,143
-4,310
-5% -$849K 0.03% 497
2024
Q2
$18.3M Buy
88,453
+9,664
+12% +$2M 0.04% 410
2024
Q1
$21.3M Buy
78,789
+11,934
+18% +$3.23M 0.05% 370
2023
Q4
$15.8M Buy
66,855
+6,913
+12% +$1.63M 0.04% 425
2023
Q3
$11.7M Buy
59,942
+8,903
+17% +$1.74M 0.04% 460
2023
Q2
$10.7M Buy
51,039
+13,592
+36% +$2.86M 0.03% 502
2023
Q1
$7.56M Buy
37,447
+3,017
+9% +$609K 0.03% 587
2022
Q4
$7.5M Buy
34,430
+4,493
+15% +$979K 0.03% 554
2022
Q3
$5.89M Buy
29,937
+1,974
+7% +$389K 0.02% 584
2022
Q2
$5.98M Buy
27,963
+1,193
+4% +$255K 0.03% 597
2022
Q1
$7.6M Buy
26,770
+5,007
+23% +$1.42M 0.03% 550
2021
Q4
$8.2M Sell
21,763
-2,147
-9% -$809K 0.03% 521
2021
Q3
$9.87M Sell
23,910
-2,262
-9% -$933K 0.04% 426
2021
Q2
$9.68M Buy
26,172
+465
+2% +$172K 0.05% 419
2021
Q1
$7.45M Sell
25,707
-160
-0.6% -$46.4K 0.04% 465
2020
Q4
$6.46M Sell
25,867
-15,392
-37% -$3.85M 0.04% 472
2020
Q3
$9.34M Sell
41,259
-3,185
-7% -$721K 0.06% 340
2020
Q2
$7.75M Sell
44,444
-1,950
-4% -$340K 0.05% 385
2020
Q1
$5.86M Buy
46,394
+10,576
+30% +$1.33M 0.05% 411
2019
Q4
$5.47M Buy
35,818
+4,748
+15% +$725K 0.04% 497
2019
Q3
$4.11M Buy
31,070
+7,434
+31% +$984K 0.03% 542
2019
Q2
$3.35M Sell
23,636
-23
-0.1% -$3.26K 0.03% 595
2019
Q1
$3.44M Buy
23,659
+616
+3% +$89.5K 0.03% 565
2018
Q4
$2.61M Buy
23,043
+1,543
+7% +$175K 0.03% 619
2018
Q3
$2.89M Buy
21,500
+947
+5% +$127K 0.03% 658
2018
Q2
$2.31M Buy
20,553
+2,414
+13% +$271K 0.02% 719
2018
Q1
$1.94M Buy
18,139
+1,943
+12% +$207K 0.02% 754
2017
Q4
$1.77M Buy
16,196
+1,366
+9% +$150K 0.02% 740
2017
Q3
$1.6M Buy
+14,830
New +$1.6M 0.02% 771
2014
Q3
Sell
-4,598
Closed -$246K 1049
2014
Q2
$246K Buy
4,598
+450
+11% +$24.1K ﹤0.01% 1217
2014
Q1
$250K Buy
+4,148
New +$250K ﹤0.01% 1136